FIVE-YEAR TIME PROFILES OF CLEARANCES OF DIFFERENT UREMIC SOLUTES IN INCIDENT PERITONEAL DIALYSIS PATIENTS

 

Certificate Output Instructions

For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".

To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".

 


 

Certificate Background

   

Presented the abstract " "
(Abstract co-author(s):  )

 

 

E-Poster Presentation

During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center. 

Preparing your E-Poster

Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.

​E-Poster Submission Deadline

Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.​

E-Poster Format Requirements
  • PDF file
  • Layout: Portrait (vertical orientation)
  • One page only (Dim A4: 210 x 297mm or PPT)
  • E-Poster can be prepared in PowerPoint (one (1) PowerPoint slide) but must be saved and submitted as PDF file.
  • File Size: Maximum file size is 2 Megabytes (2 MB)
  • No hyperlinks, animated images, animations, and slide transitions
  • Language: English
  • Include your abstract number
  • E-posters can include QR codes, tables and photos
https://storage.unitedwebnetwork.com/files/1099/1c9358e55e5c8e8c20456dbf951bde52.pdf
FIVE-YEAR TIME PROFILES OF CLEARANCES OF DIFFERENT UREMIC SOLUTES IN INCIDENT PERITONEAL DIALYSIS PATIENTS

Please follow the instructions below to input your abstract title.

Abstract titles should be brief and reflect the content of the abstract.

  • The title will not be accepted if it exceeds 25 words.
  • Type in CAPITAL LETTERS.
  • Lowercase may be used for abbreviations only, for example, mRNA.
Shengzhuo
You
Ji Ji anactive0103@163.com Zhongshan Hospital Department of Nephrology Shanghai China -
Min Lu luminous514@163.com Zhongshan Hospital Department of Nephrology Shanghai China -
Shulan Guo 15777167217@163.com Zhongshan Hospital Department of Nephrology Shanghai China -
Bo Xiang xiang.bo@zs-hospital.sh.cn Zhongshan Hospital Department of Nephrology Shanghai China -
Weiwei Wu wu.weiwei@zs-hospital.sh.cn Zhongshan Hospital Department of Nephrology Shanghai China -
Yang Li li.yang1@zs-hospital.sh.cn Zhongshan Hospital Department of Nephrology Shanghai China -
Xiaoyan Jiao jiao.xiaoyan@zs-hospital.sh.cn Zhongshan Hospital Department of Nephrology Shanghai China -
Jun Ji ji.jun@zs-hospital.sh.cn Zhongshan Hospital Department of Nephrology Shanghai China -
Xiaoqiang Ding ding.xiaoqiang@zs-hospital.sh.cn Zhongshan Hospital Department of Nephrology Shanghai China -
Shengzhuo You youshengzhuo2001@163.com Zhongshan Hospital Department of Nephrology Shanghai China *
Xiaofang Yu yu.xiaofang@zs-hospital.sh.cn Zhongshan Hospital Department of Nephrology Shanghai China -
-
-
-
-

Uremic solutes, traditionally subdivided into small water-soluble compounds, protein-bound toxins, and larger middle molecules according to their removal patterns by dialysis, accumulate in the body as kidney function decreases. Uremic solutes can be removed by peritoneal dialysis (PD) to some extent, but different uremic solutes have varying degrees of clearance due to their different chemical properties. Also, pathological and physiological changes in the kidney and peritoneum with the increase of dialysis vintage affect the clearances of uremic solutes. We observed the long-term trends of renal, peritoneal and total clearances of different uremic solutes in a PD cohort and explored the potential influence factors on uremic solutes clearances.

The 5-year time profiles of renal, peritoneal, and total clearances of creatinine, urea nitrogen (UN), uric acid (UA), trimethylamine N-oxide (TMAO), phosphate, beta-2-microglobulin(β2-MG), interleukin-6 (IL-6), indoxyl sulfate (IS), and p-cresol sulfate (PCS) were investigated in 64 PD patients. The patients were divided into an early start and a late start group according to baseline estimated glomerular filtration rate to investigate the effect of dialysis initiation timing on uremic solutes clearances. Patients were also divided into incremental peritoneal dialysis (IPD) and full-dose PD groups to investigate the impact of PD strategy on uremic solutes clearances.

1.Peritoneal clearances of creatinine, UN, UA, and phosphate increased over time, while the peritoneal clearance of IL-6 showed a downward trend. The peritoneal clearances of TMAO, β2-MG, IS, and PCS did not change significantly. Notably, there was a rapid decline in the renal clearance of water-soluble solutes and protein-bound toxins in the first year after PD initiation. 

2.Patients in early start group showed a lower level of variation and a higher average of renal clearances. But there were no significant differences in the average and variation levels of peritoneal clearances between the two groups.

3.Additionally, the average levels of total clearances of creatinine, UN, TMAO, phosphate and IS were higher in the early start group, while the average total clearance of PCS was lower. 

4.IPD patients had a higher level of total clearances of uremic solutes than full-dose PD patients in the first three years after PD initiation. The disparity between the two groups gradually diminished when the dialysis vintage reached 4–5 years.

In a long-term follow-up period, the peritoneal clearance of water-soluble small toxins increased over time, but that of protein-bound toxins and middle molecules did not. Initiating PD when residual kidney function remains at a relatively high level and performing IPD may better improve the efficiency of PD and help preserve the renal clearance of uremic solutes.

Kewords